Kim Wilber

2.2k total citations
16 papers, 1.5k citations indexed

About

Kim Wilber is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Kim Wilber has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Kim Wilber's work include Genomic variations and chromosomal abnormalities (7 papers), Cancer Genomics and Diagnostics (6 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Kim Wilber is often cited by papers focused on Genomic variations and chromosomal abnormalities (7 papers), Cancer Genomics and Diagnostics (6 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Kim Wilber collaborates with scholars based in Switzerland, United States and Germany. Kim Wilber's co-authors include Peter Schraml, Guido Sauter, Ronald Simon, Michael J. Mihatsch, Juha Kononen, Antonio Nocito, Christoph Bucher, Thomas Gasser, Holger Moch and Boriana Zaharieva and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Oncogene.

In The Last Decade

Kim Wilber

16 papers receiving 1.4k citations

Peers

Kim Wilber
Holger Dieterich Switzerland
Kim Wilber
Citations per year, relative to Kim Wilber Kim Wilber (= 1×) peers Holger Dieterich

Countries citing papers authored by Kim Wilber

Since Specialization
Citations

This map shows the geographic impact of Kim Wilber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Wilber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Wilber more than expected).

Fields of papers citing papers by Kim Wilber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Wilber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Wilber. The network helps show where Kim Wilber may publish in the future.

Co-authorship network of co-authors of Kim Wilber

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Wilber. A scholar is included among the top collaborators of Kim Wilber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Wilber. Kim Wilber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Johnson, Kirby L., Ekaterina Pestova, Kim Wilber, et al.. (2004). Microarray Analysis of Cell-Free Fetal DNA in Amniotic Fluid: a Prenatal Molecular Karyotype. The American Journal of Human Genetics. 75(3). 485–491. 60 indexed citations
3.
Al‐Kuraya, Khawla S., Peter Schraml, J. Torhorst, et al.. (2004). Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer. Cancer Research. 64(23). 8534–8540. 279 indexed citations
4.
Pestova, Ekaterina, Kim Wilber, & Walter King. (2004). Microarray-Based CGH in Cancer. Humana Press eBooks. 97. 355–376. 2 indexed citations
5.
Heselmeyer‐Haddad, Kerstin, Viktor Janz, Philip E. Castle, et al.. (2003). Detection of Genomic Amplification of the Human Telomerase Gene (TERC) in Cytologic Specimens as a Genetic Test for the Diagnosis of Cervical Dysplasia. American Journal Of Pathology. 163(4). 1405–1416. 108 indexed citations
6.
Schraml, Peter, Felix Burkhalter, Dietmar Schmidt, et al.. (2003). Combined Array Comparative Genomic Hybridization and Tissue Microarray Analysis Suggest PAK1 at 11q13.5-q14 as a Critical Oncogene Target in Ovarian Carcinoma. American Journal Of Pathology. 163(3). 985–992. 146 indexed citations
7.
Simon, Ronald, Ramin Atefy, Urs Wagner, et al.. (2003). HER‐2 and TOP2A coamplification in urinary bladder cancer. International Journal of Cancer. 107(5). 764–772. 78 indexed citations
8.
Schraml, Peter, Christoph Bucher, Heidi Bissig, et al.. (2003). Cyclin E overexpression and amplification in human tumours. The Journal of Pathology. 200(3). 375–382. 121 indexed citations
9.
Zaharieva, Boriana, Ronald Simon, Pierre‐André Diener, et al.. (2003). High‐throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. The Journal of Pathology. 201(4). 603–608. 79 indexed citations
10.
Simon, Ronald, Ramin Atefy, U. Wagner, et al.. (2002). [HER-2 and TOP 2A gene amplifications in urinary bladder carcinoma].. PubMed. 86. 176–83. 6 indexed citations
11.
Simon, Ronald, Kirsten Struckmann, Peter Schraml, et al.. (2002). Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene. 21(16). 2476–2483. 115 indexed citations
12.
Heselmeyer‐Haddad, Kerstin, Patricia Stoltzfus, Joseph Cheng, et al.. (2002). Detection of chromosomal aneuploidies and gene copy number changes in fine needle aspirates is a specific, sensitive, and objective genetic test for the diagnosis of breast cancer.. PubMed. 62(8). 2365–9. 27 indexed citations
13.
Schraml, Peter, Kirsten Struckmann, Wenting Fu, et al.. (2001). CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas. American Journal Of Pathology. 158(2). 593–601. 41 indexed citations
14.
Simon, Ronald, Antonio Nocito, Christoph Bucher, et al.. (2001). Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer. JNCI Journal of the National Cancer Institute. 93(15). 1141–1146. 238 indexed citations
16.
Jenkins, Robert B., Junqi Qian, Hyun K. Lee, et al.. (1998). A molecular cytogenetic analysis of 7q31 in prostate cancer.. PubMed. 58(4). 759–66. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026